These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 38917296)
1. MOF-Derived Oxygen-Deficient Titania-Mediated Photodynamic/Photothermal-Enhanced Immunotherapy for Tumor Treatment. Jiang X; Huang Z; Liu Z; Wang S; Qiu Y; Su X; Wang Y; Xu H ACS Appl Mater Interfaces; 2024 Jul; 16(27):34591-34606. PubMed ID: 38917296 [TBL] [Abstract][Full Text] [Related]
2. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy. Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821 [TBL] [Abstract][Full Text] [Related]
3. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer. Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591 [TBL] [Abstract][Full Text] [Related]
4. A dual-pathway pyroptosis inducer based on Au-Cu Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301 [TBL] [Abstract][Full Text] [Related]
5. Light-Triggered Nanozymes Remodel the Tumor Hypoxic and Immunosuppressive Microenvironment for Ferroptosis-Enhanced Antitumor Immunity. Fan Z; Wu S; Deng H; Li G; Huang L; Liu H ACS Nano; 2024 May; 18(19):12261-12275. PubMed ID: 38683132 [TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment ameliorative and adaptive nanoparticles with photothermal-to-photodynamic switch for cancer phototherapy. Zhang L; Yu Y; Ding K; Ji C; Zhang D; Liang P; Tang BZ; Feng G Biomaterials; 2025 Feb; 313():122771. PubMed ID: 39190940 [TBL] [Abstract][Full Text] [Related]
7. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy. Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Photothermal Tumor Immunotherapy by 1-MT Based on Zeolitic Imidazolate Framework-8 with pH-High Sensitivity. Su R; Yang Y; Wu H; Liu B; Tian X; Zhou C; Hu Y; Liu T Int J Nanomedicine; 2024; 19():8501-8517. PubMed ID: 39185344 [TBL] [Abstract][Full Text] [Related]
9. One-Pot Synthesis of a pH-Sensitive MOF Integrated with Glucose Oxidase for Amplified Tumor Photodynamic/Photothermal Therapy. Qi G; Chen K; Guan W; Xie J; Chen X; Zhang G; Yan R; Yang G ACS Appl Mater Interfaces; 2024 Sep; 16(37):49083-49091. PubMed ID: 39228328 [TBL] [Abstract][Full Text] [Related]
10. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy. Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775 [TBL] [Abstract][Full Text] [Related]
11. 2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity. Chen Z; Wu Y; Yao Z; Su J; Wang Z; Xia H; Liu S ACS Appl Mater Interfaces; 2022 Oct; 14(39):44199-44210. PubMed ID: 36165392 [TBL] [Abstract][Full Text] [Related]
12. Tumor targeted porphyrin-based metal-organic framework for photodynamic and checkpoint blockade immunotherapy. Liu Y; Zou B; Yang K; Jiao L; Zhao H; Bai P; Tian Y; Zhang R Colloids Surf B Biointerfaces; 2024 Jul; 239():113965. PubMed ID: 38772084 [TBL] [Abstract][Full Text] [Related]
13. Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect. Dong Y; Dong S; Wang Z; Feng L; Sun Q; Chen G; He F; Liu S; Li W; Yang P ACS Appl Mater Interfaces; 2020 Nov; 12(47):52479-52491. PubMed ID: 33196186 [TBL] [Abstract][Full Text] [Related]
14. Self-Adaptive Photodynamic-to-Photothermal Switch for Smart Antitumor Photoimmunotherapy. Yu Y; Wang H; Zhuang Z; Ji C; Zhang L; Li Y; Zhao Z; Ding D; Feng G; Tang BZ ACS Nano; 2024 May; 18(20):13019-13034. PubMed ID: 38723021 [TBL] [Abstract][Full Text] [Related]
15. Engineering of Upconverted Metal-Organic Frameworks for Near-Infrared Light-Triggered Combinational Photodynamic/Chemo-/Immunotherapy against Hypoxic Tumors. Shao Y; Liu B; Di Z; Zhang G; Sun LD; Li L; Yan CH J Am Chem Soc; 2020 Feb; 142(8):3939-3946. PubMed ID: 31968933 [TBL] [Abstract][Full Text] [Related]
16. Covalent Organic Framework Nanocarriers of Singlet Oxygen for Oxygen-Independent Concurrent Photothermal/Photodynamic Therapy to Ablate Hypoxic Tumors. Dutta D; Wang J; Li X; Zhou Q; Ge Z Small; 2022 Sep; 18(37):e2202369. PubMed ID: 35971160 [TBL] [Abstract][Full Text] [Related]
17. Reprogramming the Tumor Microenvironment through Second-Near-Infrared-Window Photothermal Genome Editing of PD-L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy. Tang H; Xu X; Chen Y; Xin H; Wan T; Li B; Pan H; Li D; Ping Y Adv Mater; 2021 Mar; 33(12):e2006003. PubMed ID: 33538047 [TBL] [Abstract][Full Text] [Related]
18. Decomposable Nanoagonists Enable NIR-Elicited cGAS-STING Activation for Tandem-Amplified Photodynamic-Metalloimmunotherapy. Guo X; Tu P; Wang X; Du C; Jiang W; Qiu X; Wang J; Chen L; Chen Y; Ren J Adv Mater; 2024 May; 36(21):e2313029. PubMed ID: 38353366 [TBL] [Abstract][Full Text] [Related]
19. Stimuli-Responsive Manganese Single-Atom Nanozyme for Tumor Therapy via Integrated Cascade Reactions. Zhu Y; Wang W; Cheng J; Qu Y; Dai Y; Liu M; Yu J; Wang C; Wang H; Wang S; Zhao C; Wu Y; Liu Y Angew Chem Int Ed Engl; 2021 Apr; 60(17):9480-9488. PubMed ID: 33543825 [TBL] [Abstract][Full Text] [Related]
20. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors. Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]